Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension: a population-based intervention trial from the Tromso Study

Article Abstract:

Polyunsaturated fatty acids, which occur in fish oil and other foods, have been claimed to be beneficial for people with hypertension (high blood pressure). Eskimos have a high concentration of polyunsaturated fatty acid in their diet and they also have a low incidence of death from coronary heart disease, a disease of the coronary arteries, which supply blood to the heart itself. However, reports on blood pressure among Eskimos have been contradictory. Fish oil has appeared to lower blood pressure in some studies, but not in all. A carefully designed and controlled study was carried out on 156 mildly hypertensive residents of Tromsa, Norway, to observe the effects of diet on their blood pressure. They had undergone physical examinations, laboratory tests, and electrocardiographic exams. After an initial six-month observation period during which their dietary habits were monitored, subjects were randomly assigned to receive either fish oil components (eicosapentaenoic and docosahexaenoic acids, metabolic products of arachidonic acid breakdown) or corn oil (linoleic acid) in capsule form as supplements to their regular diet. Participants were examined after five weeks and again after 10 weeks. Complete dietary information was collected and evaluated for each subject. Changes in blood pressure, extent of fish consumption, and concentration of fatty acids in blood samples were recorded. Results showed that the subjects receiving fish oil had a significant reduction in systolic (4.6mm Hg), diastolic(3.0mm Hg), and average (3.5mm Hg) blood pressure values, while those taking corn oil had no changes. The subjects in both groups with a high fish intake had lower average blood pressure than those with low fish intake. The effect of fish oil on blood pressure was not significant, however, for subjects who ate the largest amount of fish, and for these subjects, too, their diet was found to account for two-thirds of the changes in blood levels of saturated and monounsaturated fatty acids. The component of fish oil that produced blood pressure reduction is not known, although eicosapentaenoic and docosahexaenoic acids worked for this group, and the effect on blood pressure was correlated with blood levels of eicosapentaenoic but not docosahexaenoic acid. It therefore seems likely that this was the effective component. Not all subjects receiving fish oil experienced lowered blood pressure (32 percent did not). The fattiness of the fish consumed in the diet was found to be a factor here; people who did lower their blood pressure ate less fatty fish. The results demonstrate that fish oil can lower blood pressure in people with mild hypertension. (Consumer Summary produced by Reliance Medical Information).

Author: Bonaa, Kaare H., Bjerve, Kristian S., Straume, Bjorn, Gram, Inger T., Thelle, Dag
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1990
Measurement, Fatty acids

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Refractory Hypertension

Article Abstract:

Refractory hypertension is commonly due to four main causes. Ingested substances such as ethical or over-the-counter drugs may interfere with antihypertensive drugs or may raise blood pressure themselves. Excessive salt, particularly among blacks, the elderly and those with kidney problems, may cause refractory hypertension. Alcohol, caffeine, tobacco, and illicit drugs have all been indicted. Inadequate or inappropriate treatment is a second general cause. Obesity, glucose intolerance and hyperinsulinemia, all linked by insulin resistance, are major causes as they lower antihypertensive drug effectiveness. A fourth factor, the patient's willingness to follow medication and dietary rules, may contribute to treatment failure but is not a cause of refractory hypertension.

Author: Setaro, John F., Black, Henry R.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1992

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Resistant or difficult-to-control hypertension

Article Abstract:

A case study of a 70-year old woman with a long-standing history of hypertension is presented. Focus is laid on the evaluation and management of resistant hypertension as well as difficult-to-control hypertension, which is defined as persistently elevated blood pressure despite treatment with two or three drugs but not meeting strict criteria for resistant hypertension.

Author: Moser, Marvin, Setaro, John F.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2006
Case studies, Disease/Disorder overview

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Care and treatment, Hypertension
Similar abstracts:
  • Abstracts: Effects of low dose corticosteroids on bone mass in rheumatoid arthritis: a longtitudinal study. Reduced bone formation in non-steroid treated patients with rheumatoid arthritis
  • Abstracts: Helicobacter pylori and gastric carcinoma: serum antibody prevalence in populations with contrasting cancer risks
  • Abstracts: Effects of birthweight and sociodemographic variables on mental development of neonatal intensive care unit survivors
  • Abstracts: The evolution of editorial peer review. How to use an article reporting variations in the outcomes of health services
  • Abstracts: The role of infection by Opisthorchis viverrini, hepatitis B virus, and aflatoxin exposure in the etiology of liver cancer in Thailand: a correlation study
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.